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Activation of the productive phase of the human papillomavirus (HPV) life cycle in differentiated keratinocytes is coincident with high-level
expression of E1^E4 protein. To determine the role of E1^E4 in the HPV replication cycle, we constructed HPV18 mutant genomes in which
expression of the full-length E1^E4 protein was abrogated. Undifferentiated keratinocytes containing mutant genomes showed enhanced
proliferation when compared to cells containing wildtype genomes, but there were no differences in maintenance of viral episomes. Following
differentiation, cells with mutant genomes exhibited reduced levels of viral DNA amplification and late gene expression, compared to wildtype
genome-containing cells. This indicates that HPV18 E1^E4 plays an important role in regulating HPV late functions, and it may also function in
the early phase of the replication cycle. Our finding that full-length HPV18 E1^E4 protein plays a significant role in promoting viral genome
amplification concurs with a similar report with HPV31, but is in contrast to an HPV11 study where viral DNA amplification was not dependent
on full-length E1^E4 expression, and to HPV16 where only C-terminal truncations in E1^E4 abrogated vegetative genome replication. This
suggests that type-specific differences exist between various E1^E4 proteins.
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Infection of epithelial tissues by human papillomaviruses
(HPV) produces a range of clinical lesions including common
warts, genital warts and cancers of the oral cavity and anogenital
tract. Of the greater than 200 different HPVs that have been
identified, HPV types 16 (HPV16) and 18 (HPV18) are the most
common of the virus types detected in carcinomas of the cervix,
head and neck (Bosch et al., 1995; Castellsague et al., 2006;
Kreimer et al., 2005). HPVs infect cells in the basal layer of
squamous epithelia. In these undifferentiated cells the double-
stranded DNA viral genome is established as an extrachromo-⁎ Corresponding author. Fax: +44 1214144486.
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doi:10.1016/j.virol.2007.01.005somal plasmid and maintained at a low copy number. Upon
cellular differentiation, amplification of the HPV genome occurs,
followed by expression of the capsid proteins L1 and L2, and
eventual progeny virion synthesis (Hebner and Laimins, 2006).
Because HPV DNA synthesis requires the host cell replication
machinery, the virus stimulates the differentiating keratinocytes
to re-enter S-phase in order to express essential cell replication
factors and enable viral DNA amplification (Hebner and
Laimins, 2006).
Initiation of the productive phase of the HPV life cycle is
accompanied by induction of E4 expression and high levels of
this HPV protein persist throughout the virus-producing phase
(Peh et al., 2002). The E4 protein is translated from spliced
E1^E4 transcripts and contains the first five amino acids from
the E1 protein fused to the E4 coding sequence (Nasseri et al.,
1987). Transcripts encoding the E1^E4 open reading frame
(ORF) are up-regulated upon cellular differentiation, but E1^E4-
containing transcripts are also present in undifferentiated cells
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E1^E4 is the third ORF from the 5′ end of most early transcripts
and is translated only at low levels. The function of E4 in the
HPV life cycle is not known, but over-expression studies of E4
in epithelial cells have revealed several potential physiologically
relevant functions. High-levels of E1^E4 lead to disruption of
sub-nuclear structures known as nuclear dot 10 (ND10 domains)
and this maybe advantageous for successful virus replication
(Roberts et al., 2003). ND10 domains are sites intimately
involved in the replication of manyDNAviruses (Everett, 2006),
and the disruption of ND10 domains by E1^E4 is seen in cellsFig. 1. HPV18 genome-containing foreskin keratinocytes unable to express full-lengt
impaired in stable viral DNA replication. (A) Two mutations introduced at nucleotide
in the E4 ORF. The nucleotide changes are silent in the overlapping E2 coding sequen
of 16 amino acid (the E1 exon is underlined). (B) Southern analysis of equal amou
selection plasmid alone (Neo), HPV18 wildtype (WT) or mutant E4 (E4M17) genom
linear form of the HPV18 genome. HPV18 episome forms migrate as supercoils (SC)
donor keratinocytes (#1, #2, and #3), harbouring HPV18 wildtype (▲) or mutant E4competent for HPV1 replication (Roberts et al., 2003). E1^E4
has also been hypothesized to facilitate the release of newly-
synthesized virions from the upper cells of lesions, by inducing a
weakening of the cornified cell envelope (Bryan and Brown,
2000) and disturbing the intermediate filament cytoskeleton
(Doorbar et al., 1991; Roberts et al., 1993). In addition, E1^E4
has been shown to associate with mitochondria and induce
apoptosis in amanner thatmay facilitate the late stage of the virus
life cycle (Raj et al., 2004). More recent studies demonstrated
that over-expression of E4 interferes with cell proliferation and
causes cells to arrest in G2. This property is conserved betweenh E1^E4 show increased cell proliferation compared to wildtype cells, but are not
s 3467 and 3470 of the HPV18 genome insert two translation termination codons
ce. The mutant HPV18 genome is predicted to express a truncated E1^E4 protein
nts of total DNA prepared from foreskin keratinocytes, transfected with a drug
es, grown as monolayer cultures to similar passage number, and probed with a
and open-circles (OC). (C) Cell growth profiles, performed in duplicate, of three
(■) genomes.
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pathogenicity (Davy et al., 2002; Knight et al., 2004; Nakahara
et al., 2002). Since inhibition of the G2-to-M transition can also
stimulate cellular DNA synthesis (Knight et al., 2004; Nakahara
et al., 2002), this E4 function may facilitate viral genome
replication in suprabasal keratinocytes.
A genetic analysis of the E4 ORF in complete cottontail
rabbit papillomavirus (CRPV) genomes indicated that expres-
sion of a full-length E1^E4 protein is crucial for activation of
viral late functions. Whilst papilloma formation was unaffected
by loss of E4 expression, both amplification of the viral genome
and capsid expression were inhibited (Peh et al., 2004). A
similar requirement for full-length E1^E4 protein expression
was necessary for efficient induction of HPV31 late functions in
differentiated keratinocytes, and loss of E1^E4 correlated with a
failure of suprabasal cells to re-enter the cell cycle (Wilson et
al., 2005). In contrast, studies with HPV11 failed to demonstrate
any role for E1^E4 in the productive phase of the viral life cycle
(Fang et al., 2006). Similarly, studies of HPV16 indicated that
truncations of E4 at the N terminus had little inhibitory effect on
the activation of late functions, in contrast to truncations of the
C-terminus which had a significant effect (Nakahara et al.,
2005). Thus, different activities have been reported for E1^E4
proteins of various high and low risk HPV types. To ascertain
whether the productive virus life cycle of other high-risk HPV
types is dependent on full-length E4 functions, we have
investigated the effects of the loss of E1^E4 function on the
HPV18 life cycle.
Results
Loss of full-length E1^E4 expression alters cell proliferation of
undifferentiated keratinocytes, but does not affect stable
maintenance of the HPV18 genome
In order to investigate the role of the full-length E1^E4
protein in the life cycle of HPV18, we constructed mutant
genomes that contained two point mutations, T3467→A and
T3470→G, that are silent in the E2 ORF, but which introduce
two translation termination codons at positions 17 and 18 of the
E1^E4 coding sequence. This results in the synthesis of a
truncated E1^E4 protein of 16 amino acids (Fig. 1A). Wildtype
and mutant genomes were each co-transfected with a neomycin
resistance plasmid into primary human foreskin keratinocytes
(HFKs) obtained from individual foreskin donors, and after a
brief selection period the isolated clones were pooled. To ensure
that any effect upon the HPV18 life cycle is not specific to one
HFK isolate, three different foreskin donors were used to
generate cell lines containing HPV18 wildtype (WT#1, #2, and
#3) or mutant E4 (E4M17#1, #2, and #3) genomes.
The contribution of E1^E4 function to the early phase of
HPV18 genome replication was evaluated by Southern analysis
of total genomic DNA isolated from undifferentiated monolayer
cultures of HPV18 containing HFKs. The DNA samples were
digested with DpnI to remove residual input bacterial DNA, and
BglII that has no recognition sites in the HPV18 genome.
Southern analysis using an HPV18 genomic probe revealed thepresence of HPV18 episomes, migrating as supercoiled (SC)
and open circle (OC) forms, in both wildtype and mutant E4
lines of all three donor isolates (Fig. 1B). In one foreskin donor
(#2), the level of mutant E4 episomes was moderately lower
than that of wildtype genomes. However, this effect on episome
maintenance was not observed in the two other HFKs (Fig. 1B),
even upon extended passage (data not shown). We conclude that
full-length E1^E4 is not required for establishment or stable
replication of HPV18 genomes in normal keratinocytes.
Since studies using heterologous expression systems indi-
cated that HPV E4 protein expression is associated with
suppression of keratinocyte growth and induction of a G2 arrest
of the cell cycle (Davy et al., 2002; Knight et al., 2004;
Nakahara et al., 2002), we next compared the growth rates, and
the cell cycle profile, of the established HPV18 wildtype- and
E4 mutant-containing cell lines grown in monolayer culture. At
various time points, keratinocytes were harvested and viable
cells counted after removal of feeder fibroblasts (Fig. 1C). In all
sets of transfected HFKs using different donor backgrounds, the
growth rate of cells containing the mutant E4 genomes was
significantly greater than those containing wildtype genomes
(Fig. 1C). This suggests that HPV18 E1^E4 functions are
relevant in undifferentiated cells prior to the onset of viral late
functions. The significance of a possible role for E1^E4 in the
regulation of proliferation of cells in the early phase of the HPV
life cycle is not clear, but our observations are in-keeping with
the observed increase in papilloma formation by CRPV
genomes unable to express E4 (Peh et al., 2004). Cell cycle
analysis did not identify a difference between the profiles of
cells containing wildtype or mutant E4 HPV18 genomes (data
not shown).
HPV18 genome amplification and late gene transcription are
reduced in keratinocytes containing mutant E4 genomes
following differentiation by suspension in methylcellulose
To ascertain whether E1^E4 has a role in the productive
phase of the HPV18 replication cycle, viral late functions were
induced by suspension of the keratinocyte cell lines in 1.5%
methylcellulose. Total genomic DNA, and RNA, was prepared
from cells prior to suspension in methylcellulose (0 h), and after
24 and 48 h in suspension. Induction of differentiation-
dependent HPV18 genome amplification and late gene expres-
sion were examined by Southern and Northern analyses
respectively. Fig. 2A shows a typical Southern blot of cells
containing wildtype or mutant E4 HPV18 genomes. Whilst a
significant level of differentiation-dependent DNA amplifica-
tion occurred upon suspension in wildtype genome-containing
cells, there was little amplification of the mutant E4 genomes,
even after 48 h in methylcellulose. Failure of keratinocytes to
support efficient amplification of the mutant genome was
consistently observed in transfected cell lines from all three
donor HFKs (Fig. 2B). Northern blot analysis of total cellular
RNAs isolated form keratinocytes grown in monolayer culture
(0 h), demonstrated no differences in the levels of early viral
transcripts between cells containing wildtype or mutant E4
genomes (Fig. 2C).
Fig. 2. Loss of full-length E1^E4 expression impairs differentiation-dependent HPV18DNA amplification and activation of late gene expression. (A) Southern analysis
of equal amounts of total DNA extracted from HFKs transfected with wildtype (WT) or mutant E4 (E4M17) genomes and suspended in methylcellulose (MC) for
various times. HPV18 episome forms migrate as supercoils (SC) and open-circles (OC). (B) Bar graph showing amplification of WTand E4M17 genomes in a different
donor keratinocyte population. Data was derived from phosphoimaging analysis of six experiments using three matched sets of cells withWTand E4M17 genomes. (C)
Northern analysis of equal amounts of total RNA extracted fromHPV18 genome-containingHFKs following suspension inMC.Arrowheadsmark the positions of early
transcripts, and arrows indicate late transcripts. Migration of 28S and 18S RNAs is as indicated and the level of 28S RNA is a loading control. A linear form of the
HPV18 genome was used as a probe for HPV18 DNA and RNA. (D) Detection of E1^E4 protein expression by Western blot analysis of total protein lysates.
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sion occurred efficiently in keratinocytes transfected with
wildtype genomes, with significant production of the late
transcripts encoding E1^E4, E5 (Fig. 2C). However, in
comparison to the keratinocytes containing the wildtype
genomes, the induction of these late transcripts was severely
inhibited in cells containing the mutant E4 genome, with only a
low level of the transcripts accumulating in cells following
suspension in methylcellulose for 48 h (Fig. 2C). Western blot
analysis of E1^E4 expression was performed with a cross-
reactive monoclonal antibody (1D11) that is specific to the N-
terminus of E1^E4 proteins (Roberts et al., 2003). This analysis
showed that induction of wildtype HPV18 genome amplifica-
tion correlated with high-level expression of E1^E4 protein
(Fig. 2D). As expected, we were unable to detect an E4
polypeptide in mutant E4 genome transfected cells (Fig. 2D).
However, we cannot rule out the possibility that the truncated
16 amino acid N-terminal E1^E4 polypeptide that would be
produced in these cells (Fig. 1A) is stable, and furthermore, that
it is functional. Overall these observations indicate that the full-
length HPV18 E1^E4 protein is required for the differentiation-
dependent amplification of viral genomes and induction of late
gene expression.Suprabasal DNA synthesis is not inhibited in organotypic raft
cultures of keratinocytes containing mutant E4 genomes
Previous studies with HPV31 demonstrated a reduction in the
number of S-phase nuclei retained in the suprabasal cell layers of
organotypic raft cultures of cells containing genomes unable to
express E1^E4 (Wilson et al., 2005). This suggested that HPV31
E1^E4 might support differentiation-dependent viral late func-
tions by contributing to the activation, or the maintenance of an S
phase state in suprabasal cells (Wilson et al., 2005). To examine
whether S-phase re-entry of suprabasal cells is similarly affected
by mutant HPV18 E4 genomes, organotypic rafts cultures of the
HPV18 transfected cells were prepared. To identify nuclei
undergoing DNA synthesis, rafts were incubated with the
thymidine analogue bromodeoxyuridine (BrdU), prior to harvest-
ing 12 h later, and sections stained with a BrdU monoclonal
antibody. While DNA synthesis was largely restricted to cells of
the basal cell layer in raft cultures of untransfected HFKs, in
wildtype and mutant E4 rafts, BrdU-positive nuclei were detected
in both basal and suprabasal epithelial compartments (Fig. 3A).
Moreover, there was no difference found in the number of BrdU-
positive suprabasal nuclei present in raft cultures of cells con-
taining wildtype or mutant E4 genomes (Fig. 3A and data not
Fig. 3. Suprabasal DNA synthesis is not compromised by a loss of full-length E1^E4 expression. (A) Organotypic rafts cultures of keratinocytes transfected with
wildtype (WT), mutant E4 (E4M17) genomes or untransfected cells (HFK), were incubated with BrdU to identify nuclei positive for DNA synthesis.
Immunofluorescence was performed with an anti-BrdU antibody (red) and all nuclei were visualized using DAPI-staining (blue). Arrowheads indicate the basal layer.
(B) Nuclei positive for HPV18 genome amplification were identified by FISH analysis (green, arrows). Arrowheads indicate the basal layer.
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does not compromise the ability of HPV18-containing keratino-
cytes to undergo S phase re-entry upon differentiation. In order to
detect nuclei positive for viral DNA amplification, fluorescence in
situ hybridization (FISH) analysis was performed using HPV18
genomic DNA as a probe. In rafts prepared fromwildtypeHPV18
genome-containing cells, suprabasal nuclei positive for viral
DNA amplification were detected, but not in raft cultures of
untransfected ormutant E4 cells (Fig. 3B), confirming our finding
obtained from growth of cells in methylcellulose (Fig. 2A).
To confirm loss of E4 expression in the mutant E4 raft
cultures, immunocytochemistry using rabbit antibodies pre-
pared against a HPV18 E1^E4-GST fusion protein was
performed on raft sections. Expression of E4 was detected in
suprabasal cells of rafts formed by keratinocytes containing thewildtype genomes, but not untransfected cells, or those
transfected with mutant E4 genomes (Fig. 4). Interestingly,
the pattern of E4-staining in the wildtype raft cultures changed
as the cells differentiated, appearing as a cytoplasmic fibrous
distribution in nucleated cells, but becoming more punctate in
the cytoplasm of superficial cells (Fig. 4).
Discussion
In this study, we have shown that normal foreskin keratino-
cytes containing HPV18 genomes unable to express a full-
length E1^E4 protein, fail to support efficient viral genome
amplification upon differentiation. Loss of E1^E4 expression is
also associated with an inhibition of activation of viral late gene
expression. We conclude that expression of full-length E1^E4 is
Fig. 4. HPV18 E1^E4 expression in organotypic raft cultures. E1^E4 protein
accumulates in suprabasal cells of keratinocytes containing wildtype (WT), but
not mutant E4 (E4M17) genomes, or untransfected keratinocytes (HFK). Note
that as WT cells migrate upwards in the raft the distribution of E4 staining
changes. Examples of nucleated cells with a cytoplasmic fibrous E4 staining
(right hand panel) and a more superficial cell showing punctate E4 distribution
(left hand panel) are shown at high magnification.
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HPV18. Our findings are consistent with those of two previous
studies, one of the life cycle of CRPV in vivo (Peh et al., 2004),
and the other that examined the HPV31 replication cycle in
normal foreskin keratinocytes induced to differentiate in tissue
culture (Wilson et al., 2005). Both identified a critical role for
E4 in papillomavirus genome amplification and late gene
expression. However, it has recently been reported that
expression of a full-length E1^E4 protein was not necessary
for efficient HPV11 genome amplification in organotypic raft
culture (Fang et al., 2006). One explanation for a non-essential
role of E1^E4 in HPV11 genome amplification would be a
difference in E1^E4 function between HPV types that exhibit
dissimilar pathogenicity and tropism; HPV11 infections are
primarily of the external genitalia and the larynx, with lesions
having only a low-risk of becoming malignant, whilst infections
induced by HPV16, 18 and 31 are most common at the mucosal
sites of the genitalia and oral epithelia, and have a high-risk of
malignant conversion. Indeed, E6 and E7 proteins of the high-
risk virus types mediate different biological functions to those
of the low-risk viruses (Hebner and Laimins, 2006).In the HPV11 study, the mutant genomes express a truncated
E1^E4 protein that terminates at a similar position as those of
HPV18 and 31. For HPV11, the translation stop codon was
introduced immediately before a conserved N-terminal leucine
motif (HPV11, MADDSALYEKYP), while in the HPV18 and
31 proteins termination occurs within the motif itself (HPV18,
MADPEVPVTTRYPLLS; HPV31, MADPAAVTKYPLLG,
the initial part of the leucine motif LLXLL is underlined).
Since it is known that the N-terminus of E1^E4 plays an
important role in several biological properties of E4 (Raj et al.,
2004; Roberts et al., 1994, 2003), it is plausible that the
truncated E1^E4 peptide of HPV11, but not of HPV18 or 31, is
able to mediate functions required to support viral DNA
amplification. An alternative explanation for the differences in
E1^E4 function could be that different experimental systems
were used to assess the role of E1^E4 in the virus life cycles.
The HPV11 life cycle was examined in N-Tert cells, a human
foreskin keratinocyte cell line immortalized by the catalytic
subunit of human telomerase (Fang et al., 2006), while in our
analysis we transfected HPV18 genomes into normal primary
foreskin keratinocytes, the same target cell as that used in the
HPV31 study (Wilson et al., 2005). It is possible that the
immortalized keratinocyte cell line compensates in some
manner for the lack of those E1^E4 functions that might be
required for viral DNA amplification. It is interesting to note
that loss of E4 function in the more divergent virus type CRPV
correlates with life cycle defects similar to those observed with
HPV18 and HPV31 mutant genomes (Peh et al., 2004). It could
be argued that since the analysis of CRPV E4 function involved
re-introduction of the mutant CRPV genomes into the skin of
rabbits (i.e. into primary keratinocytes), this study is analogous
to those of HPV18 and HPV31 that were also performed in
primary cells, but not the HPV11 study in immortalized cells.
A more complicated phenotype was reported in studies on
HPV16 E1^E4 which indicated that the differentiation-depen-
dent amplification phase of HPV16 genome replication was not
significantly affected following transfection into normal
immortalized keratinocytes (NIKS) of mutant genomes that
expresses a similarly truncated E1^E4 protein (MADPAAAT-
KYPLLK, 16st15) (Nakahara et al., 2005). However, deletion
of the C-terminal third of E4 led to inhibition of HPV16 genome
amplification, while truncation mutations that resulted in
smaller HPV16 E1^E4 proteins seemed to enhance amplifica-
tion. The authors hypothesized that these smaller truncations of
HPV16 E1^E4 represent gain-of-function mutations. This study
also used immortalized keratinocytes and this may contribute to
the differences observed. Alternatively, it could reflect impor-
tant type-specific differences.
Our studies also demonstrated that while loss of E1^E4
expression inhibited efficient HPV18 genome amplification in
differentiating keratinocytes, there was no corresponding
reduction of suprabasal cellular DNA synthesis. This is in
contrast to studies examining keratinocytes containing the
equivalent E1^E4 mutants of HPV16 (16st15) and HPV31
(E4M9) genomes, which both showed a decrease in suprabasal
DNA synthesis (Nakahara et al., 2005; Wilson et al., 2005).
While this action of E1^E4 might be significant for HPV16 and
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further underscores that fact that differences exist in the modes
of action of E1^E4 proteins from various HPV types.
In addition to effects in differentiated cells we also observed
effects due to HPV18 E1^E4 in undifferentiated cells. HFKs
transfected with the mutant HPV18 E4 genomes showed
enhanced proliferation of undifferentiated cells when compared
to the growth of cells containing the wildtype genomes.
Although E1^E4 protein expression is most abundant in cells
competent for viral DNA amplification and virion production,
transcripts containing the spliced E1^E4 genes are produced
during the virus non-productive phase (Stubenrauch and
Laimins, 1999). Genetic studies have demonstrated that E1 is
expressed in undifferentiated cells (Frattini et al., 1996) so it is
likely that E1^E4 is also synthesized in these cells as it shares
common N-terminal amino acids. It is therefore possible that
E1^E4 proteins contribute to an early viral function that affects
cell growth. The effect of HPV18 E1^E4 on cell proliferation
does not appear to be connected to viral DNA replication in
undifferentiated cells since there were no obvious differences
between the levels of episome forms between the wildtype or E4
mutant cells. A role for E1^E4 in the early phase of the virus life
cycle is also supported by the observation that HPV16 DNA
replication is inhibited in undifferentiated NIKS cells trans-
fected with genomes carrying mutations within the N-terminal
leucine-rich motif of E4 (Nakahara et al., 2005).
Overall our studies have demonstrated that E1^E4 from
HPV18 plays an important role in regulating late viral functions.
In addition, they demonstrate that type-specific differences exist
between various E1^E4 proteins which is consistent with the
high degree of sequence variability of this viral protein among
the different HPV types.
Materials and methods
Construction of mutant HPV18 genomes
A pGEMII plasmid containing the complete HPV18 genome
inserted at the EcoRI restriction site at nucleotide 2440
(pGEMII18-WT, a gift from Frank Stubenrauch, University of
Tuebingen) was used as a template for site-directed mutagenesis
(QuikChange, Stratagene) of the E4 ORF. Two nucleotide
substitutions (T3467→A and T3470→G)were inserted into the E4
ORF using the primer set, 5′-CGG TAT CCG CTA CTC AGC
TAG TGA AAC AGC TAC AGC ACA CCC-3′ (forward
primer) and 5′-TGTGCTGTAGCTGTTTCACTAGCTGAG
TAG CGG ATA CCG-3′ (reverse primer). These changes are
silent in the overlapping E2 coding sequence but introduce two
translation stop codons into E4 that direct termination of the
E1^E4 protein after amino acid 16. The complete genomes were
sequenced to confirm that mutations, other than those introduced
into E4, had not been introduced elsewhere during mutagenesis.
Cell transfections
Isolation of normal human foreskin keratinocytes from
neonatal foreskin and maintenance of cells in SFM keratinocytegrowth media (Invitrogen-Gibco) has been described previously
(Wilson et al., 2005). Plasmids containing the wildtype and
mutant E4 genomes were digested by EcoRI to release the
HPV18 genomes, and the genomes re-circularized in the
presence of T4 DNA ligase (400 U/ml, New England Bio-
technologies) prior to co-transfection with a plasmid containing
a neomycin resistance gene, into second-passage HFKs, using
the protocols described (Wilson et al., 2005). Subsequent
selection of cells in G418- and serum-containing medium (E
medium) for 8 days and the culture of pooled clones on feeder
layers of mitomycin C-treated J2-3T3 fibroblasts, was as
described (Wilson et al., 2005).
Methylcellulose suspension
Cell differentiation was induced in monolayer cultures of un-
transfected and HPV18-transfected keratinocytes by transfer of
cells to 1.5%methylcellulose prepared in Emedium as described
previously (Wilson et al., 2005).
Organotypic raft culture
Preparation of organotypic rafts cultures was as previously
described (Wilson et al., 2005). Briefly, each HPV18-containing
keratinocyte line was grown in organotypic raft culture by
seeding onto a collagen bed containing J2-3T3 fibroblasts, and
transferred onto a metal grid once a confluent state had been
reached. Cell stratification was allowed to proceed for 13 days
and the rafts then harvested. Cellular DNA synthesis was
monitored by addition of 20 μM BrdU to the raft culture
medium 12 h prior to harvest. Tissue sections were prepared
from formaldehyde fixed and paraffin-embedded rafts. If rafts
were labelled with BrdU, sections were immunostained with an
antibody specific for BrdU.
For examination of E4 expression, the formaldehyde-fixed
raft sections were treated using a low temperature method of
antigen retrieval (Watson et al., 2002) and then incubated with
rabbit polyclonal antibodies raised against an glutathione-S-
transferase HPV18 E1^E4 fusion protein. Immune complexes
were identified by a rabbit IgG-specific Alexa® 594 conjugate
(Molecular Probes Inc) and nuclei stained with 4′, 6′-diamidino-
2-phenylindole (DAPI), prior to mounting in ProFade (Mole-
cular Probes Inc).
FISH
Fluorescence in situ hybridization (FISH) using digox-
igenin labelled HPV18 genomic probe was performed on
formaldehyde-fixed raft sections as previously described
(Wilson et al., 2005).
Southern and Northern analysis
Protocols for DNA extraction and Southern and Northern
analysis of nucleic acids isolated from HPV genome-containing
keratinocyte lines have been described elsewhere (Wilson et al.,
2005). Briefly, for Southern analysis, total genomic DNA was
460 R. Wilson et al. / Virology 362 (2007) 453–460prepared from cell cultures using the described method, or by
using a DNA extraction kit (Nucleon HT, Amersham Bio-
sciences). Samples (5 μg) were treated with DpnI to digest
residual input DNA and BglII. No BglII sites exist in the
HPV18 genome. The digested DNAs were run on 0.8% agarose
gels and DNA transferred to GeneScreen™ nylon membrane
(PerkinElmer, Wellesley, MA). Complete HPV18 genomic
DNA was released from the pGEMII backbone by digestion
with EcoRI, purified and labelled with [α-32P]-CTP (Amersham
BioSciences). The membrane was incubated with the radio-
labelled HPV18 linear probe at 42 °C overnight and following
washing was exposed to autoradiograph film or band
intensities quantitated by PhosphorImager analysis (Molecular
Dynamics, GE Healthcare Ltd). RNA samples were extracted
from cell cultures using RNA STAT-60 (ams Biotechnology,
Abingdon, Oxon, UK), according to manufacturer’s instruc-
tions, and Northern analysis performed using a radiolabelled
HPV18 probe as described.
Western analysis
Total protein was extracted from keratinocytes suspended in
methylcellulose by lysis in 9 M urea, 25 mM Tris–HCl (pH
7.6), 150 mM NaCl, 0.15 M β-mercaptoethanol. Equal amounts
of protein were separated by SDS-polyacrylamide electrohor-
esis, transferred to nitrocellulose membrane and the membrane
incubated with a monoclonal antibody 1D11 (Roberts et al.,
2003) specific for the N-termini of E1^E4 proteins. After
incubation with anti-mouse IgG specific peroxidase conjugate
(Sigma Chemicals) the membrane was developed by chemilu-
minescence (Amersham Biosciences).
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